Serum Institute Receives Approval To Launch Covovax Trials On Children Aged 7-11
Photo: Swarajyamag

Serum Institute Receives Approval To Launch Covovax Trials On Children Aged 7-11

Serum Institute of India has received permission to conduct clinical trials of Covovax among children aged 7 to 11 years. According to reports, the SII-manufactured Novavax vaccine, Covovax, could be available for approval for use in children as early as January or February 2022. .… Read More

Visit www.werindia.com OR Hindi.werindia.com to read news from 500+ news sources... आपका अपना डिजिटल अख़बार |

Leave a Reply